Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion
April 27 (Reuters) - Thermo Fisher Scientific TMO.N said on Monday it has agreed to sell its microbiology business to a pan-European private equity firm Astorg for about $1.08 billion, consisting of cash and a $50 million seller note. (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Thermo Fisher Scientific
See all newsU.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
U.S. STOCKS ON THE MOVE-Thermo Fisher, CME
Thermo Fisher rises after Q3 beat
Thermo Fisher Scientific Inc. reports results for the quarter ended September 30 - Earnings Summary
Thermo Fisher Q3 revenue, adj profit beat estimates after new product launches